简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-04-27 14:36 SpeeDx Receives CE-IVD Mark for PlexPCR® SARS-CoV-2
2021-04-26 09:24 LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021
2021-04-26 09:19 Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use During the COVID-19 Pandemic
2021-04-26 09:08 LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis
2021-04-23 19:07 MSCI Announces Strategic Alliance With Royalty Pharma to Launch Life Sciences Indexes
2021-04-23 13:34 Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
2021-04-23 10:14 Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
2021-04-21 16:42 Pacific Telecommunications Council Announces the Call for Participation for Its 44th Annual Conference
2021-04-21 15:54 Take ‘VOW’ to Protect All Humanity: ‘Vaccinate Our World!’
2021-04-21 13:27 PTT Invests in Lotus Pharmaceutical's Strategic Partnership in South East Asia
2021-04-21 10:29 Asahi Kasei Medical Bioprocess Affiliate Opens in China
2021-04-16 16:43 Evobrutinib is the First and Only BTK Inhibitor to Demonstrate Reduction of a Key Biomarker of Neuronal Damage and Inflammation in Patients with MS
2021-04-15 19:44 Games Industry Reflects on and Recommits to #PlayApartTogether Campaign at One Year Milestone
2021-04-15 15:34 RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs
2021-04-15 14:32 Noxopharm Files Septic Shock Treatment Patent for Veyonda®
2021-04-15 09:29 Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer
2021-04-14 15:15 LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
2021-04-14 10:33 CORRECTING and REPLACING Illumina Named One of Singapore’s Best Employers
2021-04-14 10:30 Diaceutics Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific
2021-04-14 09:47 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity

Business Wire Weibo

Press Releases

Latest Releases